Overview

Immunocore Holdings Plc is a pioneering biotechnology company focused on developing T cell receptor-based therapeutics to treat cancer, infectious diseases, and autoimmune conditions. The company's innovative immune-oncology approach uniquely harnesses and enhances the body's intrinsic immune capabilities to selectively target and combat specific diseases.

Therapeutic areas

FDA compliance signals

1 FDA enforcement record linked to this company.

  • recall — Class II2025-09-10

    Subpotent Drug

Verified Supplier Partner

Is this Immunocore Holdings Plc? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.